| Model Number |
CREP G2 |
| Medical Device Problem Code |
Non Reproducible Results (4029)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/12/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The field service engineer (fse) decontaminated the line and confirmed the cuvette levels.The ultrasonic mixers were checked and adjusted.The fse ran daily and weekly maintenance, cell blank, and a photometer check.Calibration and qc passed.The investigation is ongoing.
|
| |
|
Event or Problem Description
|
|
The initial reporter stated they received discrepant results for an unspecified number of patient samples tested with the crep2 (creatinine plus ver.2) assay on a cobas 8000 c702 module, serial number (b)(6).The following examples of discrepant crep2 results were provided by the customer: patient sample 1: the sample initially resulted in a crep2 value of 259 umol/l and repeated as 179 umol/l on the second instrument line, c702 module serial number (b)(6).Patient sample 2: the sample initially resulted in a crep2 value of 60 umol/l.The sample was repeated three times on the second instrument line, c702 module serial number (b)(6), resulting in values of 42 umol/l, 45 umol/l and 111 umol/l.It was asked but it is unclear which results are correct.No questionable results were reported outside of the laboratory.
|
| |
|
Additional Manufacturer Narrative
|
|
The initial report stated the second instrument line, c702 module serial number was (b)(6).The second instrument line, c702 module serial number was (b)(6).
|
| |
|
Additional Manufacturer Narrative
|
|
Frequent "abnormal sample aspiration" and "sample short" alarms were observed on the alarm trace data.Based on the information provided, the investigation did not identify a product problem.The cause of the event could not be determined.
|
| |
|
Search Alerts/Recalls
|